|
|
|
Volumn 22, Issue 4 SUPPL. 9, 1995, Pages 30-33
|
|
Paclitaxel plus carboplatin for advanced lung cancer: Preliminary results of a Vanderbilt University Phase II Trial - LUN-46
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CARBOPLATIN;
CIMETIDINE;
DEXAMETHASONE;
DIPHENHYDRAMINE;
GRANULOCYTE COLONY STIMULATING FACTOR;
LORAZEPAM;
ONDANSETRON;
PACLITAXEL;
ADULT;
AGED;
ALOPECIA;
ARTHRALGIA;
BONE MARROW SUPPRESSION;
CANCER COMBINATION CHEMOTHERAPY;
CANCER SURVIVAL;
CLINICAL TRIAL;
CONFERENCE PAPER;
DOSE RESPONSE;
FEMALE;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LUNG NON SMALL CELL CANCER;
MAJOR CLINICAL STUDY;
MALE;
MYALGIA;
NAUSEA;
ORAL DRUG ADMINISTRATION;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BONE MARROW;
CARBOPLATIN;
CARCINOMA, NON-SMALL-CELL LUNG;
COHORT STUDIES;
DISEASE PROGRESSION;
FEMALE;
HUMAN;
LUNG NEOPLASMS;
MALE;
MIDDLE AGE;
NEOPLASM STAGING;
PACLITAXEL;
REMISSION INDUCTION;
SURVIVAL RATE;
TENNESSEE;
THROMBOCYTOPENIA;
|
|
EID: 0029056179
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (16)
|
|
References (0)
|
